Dan Peizer Reveals Catalant’s Newest Acquisition

LAIs

Seven Biotechs Developing Long-Acting Injectable Drugs

Vedangi Joshi

Nice Insight

Self-Injection

The Quiet Revolution in How We Take Our Medicine

Ravi Kumar

OneSource Specialty Pharma

Critical Materials

Securing Critical Materials for Resilient Biopharmaceutical Manufacturing

Pharma's Almanac

Vaccines

The Next Generation of Vaccine Platforms

David Alvaro, Ph.D.

Pharma's Almanac

In Vivo CAR-T

Five Companies Bringing In Vivo CAR-T Therapy Closer to the Clinic

Emma Gormlie

Nice Insight

Combination Products

Collaboration is Key to Successful Injectable Drug–Device Combination Product Development

Cynthia A. Challener, Ph.D.

Pharma's Almanac

Oncology

Harnessing Macrophage Biology to Overcome Tumor Immune Evasion

Roy Maute, Ph.D.

Pheast Therapeutics

Stem Cells

Stem Cell Therapies: Close to Transforming Promise into Real Patient Outcomes

Cynthia A. Challener, Ph.D.

Pharma's Almanac

AI-Optimized CLD

From Screening to Design: Can Production Cell Lines Become Programmable Platforms?

David Alvaro, Ph.D.

Pharma's Almanac

Rare Cancer CGT

Developing Cell and Gene Therapies for Rare Oncology Applications

David Alvaro, Ph.D.

Pharma's Almanac

High-Concentration

High-Concentration Biologics Are Redefining Subcutaneous Delivery

Pharma's Almanac